As It Soaks Up Good Trial Results, Amarin Ponders Partners - Or None
This article was originally published in The Pink Sheet Daily
Executive Summary
A second set of clinical trial results expands the potential market for AMR101 tenfold, triggering increased investor and partnership interest.